591 - Validated Novel Genetic Risk Variants can Predict Anti-TNF Agent Response in Inflammatory Bowel Disease Patients

Authors :: William A. Faubion
Ming-Hsi Wang
Laura H. Raffals
Michael F. Picco
Shabana F. Pasha
Rodney D. Newberry
Jonathan A. Leighton
Jessica Friton
Source :: Gastroenterology. 154:S-125
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Hepatology
business.industry
Immunology
Gastroenterology
medicine
Tumor necrosis factor alpha
Genetic risk
medicine.disease
business
Inflammatory bowel disease

Full Text Access

Tools